Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.256
AS - Asia 4.161
EU - Europa 3.220
SA - Sud America 685
Continente sconosciuto - Info sul continente non disponibili 376
AF - Africa 118
OC - Oceania 13
Totale 15.829
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.750
SG - Singapore 1.548
CN - Cina 810
IT - Italia 749
HK - Hong Kong 600
RU - Federazione Russa 566
DE - Germania 560
VN - Vietnam 557
BR - Brasile 489
CA - Canada 442
IE - Irlanda 325
SE - Svezia 300
GB - Regno Unito 160
FR - Francia 154
IN - India 128
AT - Austria 105
BD - Bangladesh 101
UA - Ucraina 85
AR - Argentina 76
ID - Indonesia 67
KR - Corea 63
FI - Finlandia 49
IQ - Iraq 43
ZA - Sudafrica 41
PK - Pakistan 40
TR - Turchia 39
MX - Messico 36
EC - Ecuador 34
JP - Giappone 33
DK - Danimarca 29
CO - Colombia 27
PL - Polonia 26
SA - Arabia Saudita 24
ES - Italia 21
NL - Olanda 20
UZ - Uzbekistan 20
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 14
EG - Egitto 13
PY - Paraguay 12
TN - Tunisia 12
CL - Cile 11
MY - Malesia 10
PE - Perù 10
AU - Australia 9
ET - Etiopia 8
TH - Thailandia 8
BG - Bulgaria 7
JO - Giordania 7
KE - Kenya 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
KG - Kirghizistan 6
LT - Lituania 6
SN - Senegal 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
MK - Macedonia 5
NG - Nigeria 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EU - Europa 4
HN - Honduras 4
IR - Iran 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
UY - Uruguay 4
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BH - Bahrain 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
MU - Mauritius 2
NI - Nicaragua 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
Totale 15.437
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 854
Hong Kong 585
Ashburn 551
Fairfield 495
San Jose 475
Frankfurt am Main 414
Toronto 386
Chandler 316
Dublin 313
Milan 271
Wilmington 259
Woodbridge 221
New York 217
Houston 216
Seattle 213
Dallas 190
Ho Chi Minh City 165
Dearborn 139
Beijing 137
Princeton 130
Cambridge 124
Chicago 124
Hanoi 124
Santa Clara 124
Los Angeles 118
The Dalles 108
Vienna 96
Hefei 81
Moscow 76
Jacksonville 73
Lauterbourg 69
Rome 62
Altamura 58
Lawrence 56
Seoul 56
Nanjing 50
Boardman 47
Buffalo 47
Shanghai 46
Council Bluffs 45
São Paulo 44
Jakarta 41
Atlanta 39
San Diego 34
Dong Ket 33
Munich 30
Haiphong 28
London 27
Helsinki 25
Da Nang 24
Lissone 24
Orem 24
Guangzhou 23
Tokyo 23
Baghdad 22
Montreal 21
Andover 19
Salt Lake City 19
Turin 19
Warsaw 18
Brooklyn 17
Nanchang 17
San Francisco 17
Tashkent 17
Figino 15
Kunming 15
Jiaxing 14
Phoenix 14
Rio de Janeiro 14
Shenyang 14
Belo Horizonte 13
Columbus 13
Denver 13
Mumbai 13
Tianjin 13
Brussels 12
Changsha 12
Chennai 12
Nuremberg 12
Poplar 12
Johannesburg 11
Lahore 11
Memphis 11
Quito 11
Jeddah 10
Jinan 10
Bologna 9
Brasília 9
Cairo 9
Hebei 9
Manchester 9
Mexico City 9
Miami 9
Pune 9
Falls Church 8
Hangzhou 8
Lappeenranta 8
Medellín 8
Turku 8
Totale 10.000
Salva come PNG Salva come JPEG
Nome #
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 346
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 334
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 329
Heart rate as cardiovascular risk factor 314
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 288
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 287
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 283
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 281
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 280
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 276
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 269
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 266
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 265
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 258
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 252
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 250
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 249
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 242
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 241
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 240
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 238
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 237
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 227
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 223
Sympathetic Nervous System, Sleep, and Hypertension 209
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 209
Baroreflex activation therapy systems: current status and future prospects 207
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 205
Effects of Renal Denervation on Sympathetic Nervous System Activity 201
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 200
The role of carotid baroreceptor stimulation 198
Obesity and Hypertension 191
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 190
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 185
Elevated heart rate as sympathetic biomarker in human obesity 184
Blood pressure measurement, white-coat and masked hypertension 183
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 183
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 181
The role of brain in neurogenic prehypertension 181
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 178
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 177
Sympatho-Vagal Imbalance in Hypertension 177
Heart rate as a predictor of cardiovascular risk 175
New-onset aortic dilatation in the population: a quarter-century follow-up 174
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 174
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 170
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 167
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 167
Lercanidipine in the management of hypertension: An update 165
Obesity and hypertension 163
Clinical relevance of the sympathetic–vascular interactions in health and disease 163
Sleep Apnea and Hypertension 160
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 159
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 158
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 154
Neural Mechanisms 153
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 152
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 151
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 151
Device-Based Treatment in Hypertension and Heart Failure 150
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 149
Cardiovascular physiology: regulation of blood pressure 149
Treatment of resistant hypertension 148
Cigarette smoking and the adrenergic nervous system 148
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 146
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 145
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 144
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 139
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 138
Neurohormonal interactions 137
Baroreceptor Stimulation 136
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 135
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 133
Arterial alterations in hypertension 131
Sympathetic Activity in Hypertension and Heart Failure 126
Trained Athletes 123
Sympathomodulation in congestive heart failure: From drugs to devices 120
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 119
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 118
Microvascular Alterations in Obesity 117
The sympathetic nervous system in hypertension 106
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 105
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 97
Totale 15.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20266.245 519 310 489 665 653 319 950 299 455 496 551 539
2026/2027181 181 0 0 0 0 0 0 0 0 0 0 0
Totale 15.829